|
Market Closed -
Nasdaq
21:00:00 08/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 9.840 USD | -0.61% |
|
-0.81% | +60.00% |
| 08-14 | ImmuCell Corporation, Q2 2026 Earnings Call, Aug 14, 2026 | |
| 08-13 | ImmuCell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 89.91M | - | - | - | - | - |
| 1,024B | |||||
| 663B | - | - | - | ||
| 453B | |||||
| 349B | |||||
| 295B |
- Stock Market
- Stocks
- ICCC Stock
- Charts ImmuCell Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
